Structure

Physi-Chem Properties

Molecular Weight:  504.17
Volume:  472.318
LogP:  0.98
LogD:  0.057
LogS:  -4.563
# Rotatable Bonds:  4
TPSA:  184.08
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.243
Synthetic Accessibility Score:  4.458
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.387
MDCK Permeability:  4.087917841388844e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.349
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.065
Plasma Protein Binding (PPB):  90.65750885009766%
Volume Distribution (VD):  0.792
Pgp-substrate:  7.589847564697266%

ADMET: Metabolism

CYP1A2-inhibitor:  0.142
CYP1A2-substrate:  0.097
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.504
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.428
CYP2D6-inhibitor:  0.074
CYP2D6-substrate:  0.36
CYP3A4-inhibitor:  0.018
CYP3A4-substrate:  0.019

ADMET: Excretion

Clearance (CL):  1.113
Half-life (T1/2):  0.574

ADMET: Toxicity

hERG Blockers:  0.113
Human Hepatotoxicity (H-HT):  0.078
Drug-inuced Liver Injury (DILI):  0.897
AMES Toxicity:  0.515
Rat Oral Acute Toxicity:  0.028
Maximum Recommended Daily Dose:  0.006
Skin Sensitization:  0.151
Carcinogencity:  0.293
Eye Corrosion:  0.003
Eye Irritation:  0.015
Respiratory Toxicity:  0.399

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC308392

Natural Product ID:  NPC308392
Common Name*:   Sophenazine F
IUPAC Name:   (2S,3R,4R,5R,6S)-2-methyl-6-[6-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenazin-1-yl]oxyoxane-3,4,5-triol
Synonyms:   Sophenazine F
Standard InCHIKey:  HHDAJEKYCDPELA-MQFMLQFSSA-N
Standard InCHI:  InChI=1S/C24H28N2O10/c1-9-17(27)19(29)21(31)23(33-9)35-13-7-3-5-11-15(13)25-12-6-4-8-14(16(12)26-11)36-24-22(32)20(30)18(28)10(2)34-24/h3-10,17-24,27-32H,1-2H3/t9-,10-,17-,18-,19+,20+,21+,22+,23-,24-/m0/s1
SMILES:  O[C@H]1[C@@H](O[C@H]([C@@H]([C@H]1O)O)C)Oc1cccc2c1nc1cccc(c1n2)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2334063
PubChem CID:   71524394
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33439 streptomyces sp. strain dl-93 Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[23317013]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. EC50 = 45000.0 nM PMID[500061]
NPT20 Organism Candida albicans Candida albicans MIC > 25.0 ug.mL-1 PMID[500061]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans MIC > 25.0 ug.mL-1 PMID[500061]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC > 25.0 ug.mL-1 PMID[500061]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 25.0 ug.mL-1 PMID[500061]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC > 25.0 ug.mL-1 PMID[500061]
NPT19 Organism Escherichia coli Escherichia coli MIC > 25.0 ug.mL-1 PMID[500061]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. MIC > 25.0 ug.mL-1 PMID[500061]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC > 25.0 ug.mL-1 PMID[500061]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 25.0 ug.mL-1 PMID[500061]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC308392 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9365 High Similarity NPC471736
0.8571 High Similarity NPC110741
0.8548 High Similarity NPC118776
0.8519 High Similarity NPC310618
0.838 Intermediate Similarity NPC124300
0.8341 Intermediate Similarity NPC291609
0.8261 Intermediate Similarity NPC1527
0.7833 Intermediate Similarity NPC470586
0.7754 Intermediate Similarity NPC79911
0.7701 Intermediate Similarity NPC120798
0.7701 Intermediate Similarity NPC285635
0.7696 Intermediate Similarity NPC258773
0.7526 Intermediate Similarity NPC95898
0.75 Intermediate Similarity NPC472434
0.7488 Intermediate Similarity NPC226202
0.7445 Intermediate Similarity NPC99891
0.7383 Intermediate Similarity NPC203168
0.7371 Intermediate Similarity NPC219664
0.7363 Intermediate Similarity NPC314573
0.7319 Intermediate Similarity NPC472435
0.7317 Intermediate Similarity NPC79293
0.7317 Intermediate Similarity NPC279401
0.7294 Intermediate Similarity NPC197141
0.7281 Intermediate Similarity NPC288349
0.7269 Intermediate Similarity NPC306644
0.7269 Intermediate Similarity NPC236424
0.7249 Intermediate Similarity NPC36168
0.7235 Intermediate Similarity NPC274842
0.7227 Intermediate Similarity NPC472436
0.7204 Intermediate Similarity NPC66815
0.7164 Intermediate Similarity NPC219963
0.7143 Intermediate Similarity NPC244856
0.7119 Intermediate Similarity NPC227824
0.7059 Intermediate Similarity NPC42591
0.7059 Intermediate Similarity NPC20249
0.703 Intermediate Similarity NPC478023
0.701 Intermediate Similarity NPC62069
0.6995 Remote Similarity NPC161887
0.6995 Remote Similarity NPC266551
0.6995 Remote Similarity NPC112766
0.6991 Remote Similarity NPC474595
0.6951 Remote Similarity NPC148409
0.6944 Remote Similarity NPC472111
0.6931 Remote Similarity NPC220560
0.6931 Remote Similarity NPC283152
0.6927 Remote Similarity NPC469589
0.6916 Remote Similarity NPC200888
0.6906 Remote Similarity NPC469594
0.6881 Remote Similarity NPC290069
0.6881 Remote Similarity NPC194724
0.6872 Remote Similarity NPC70549
0.6852 Remote Similarity NPC469440
0.684 Remote Similarity NPC469554
0.6833 Remote Similarity NPC473800
0.6826 Remote Similarity NPC476998
0.6826 Remote Similarity NPC476996
0.682 Remote Similarity NPC164374
0.682 Remote Similarity NPC137929
0.6814 Remote Similarity NPC90019
0.6802 Remote Similarity NPC474594
0.6802 Remote Similarity NPC471080
0.6802 Remote Similarity NPC469592
0.6783 Remote Similarity NPC476994
0.6783 Remote Similarity NPC476997
0.6779 Remote Similarity NPC204385
0.6771 Remote Similarity NPC153452
0.6763 Remote Similarity NPC320394
0.6757 Remote Similarity NPC26679
0.6754 Remote Similarity NPC470395
0.6752 Remote Similarity NPC57453
0.6734 Remote Similarity NPC118511
0.6733 Remote Similarity NPC14651
0.6733 Remote Similarity NPC121658
0.673 Remote Similarity NPC469390
0.6725 Remote Similarity NPC212766
0.6725 Remote Similarity NPC289423
0.6716 Remote Similarity NPC288943
0.6701 Remote Similarity NPC26850
0.6683 Remote Similarity NPC476518
0.6667 Remote Similarity NPC110151
0.6667 Remote Similarity NPC18487
0.6667 Remote Similarity NPC470799
0.6667 Remote Similarity NPC66083
0.6667 Remote Similarity NPC8022
0.6667 Remote Similarity NPC128823
0.6653 Remote Similarity NPC476995
0.6652 Remote Similarity NPC250448
0.6652 Remote Similarity NPC470931
0.6651 Remote Similarity NPC311357
0.6649 Remote Similarity NPC470403
0.6649 Remote Similarity NPC470404
0.6649 Remote Similarity NPC470394
0.6636 Remote Similarity NPC304183
0.6636 Remote Similarity NPC476106
0.6624 Remote Similarity NPC101543
0.6623 Remote Similarity NPC128115
0.6622 Remote Similarity NPC185782
0.6618 Remote Similarity NPC478032
0.6598 Remote Similarity NPC58209
0.6591 Remote Similarity NPC118832
0.6591 Remote Similarity NPC470930
0.6591 Remote Similarity NPC47059
0.6591 Remote Similarity NPC274291
0.6591 Remote Similarity NPC165349
0.6591 Remote Similarity NPC329708
0.6591 Remote Similarity NPC264166
0.6587 Remote Similarity NPC206201
0.6584 Remote Similarity NPC165964
0.6582 Remote Similarity NPC153769
0.6581 Remote Similarity NPC476999
0.658 Remote Similarity NPC473769
0.6579 Remote Similarity NPC473179
0.6574 Remote Similarity NPC267928
0.6574 Remote Similarity NPC474188
0.6567 Remote Similarity NPC314954
0.6561 Remote Similarity NPC474145
0.6561 Remote Similarity NPC475841
0.6548 Remote Similarity NPC26872
0.6547 Remote Similarity NPC209769
0.6545 Remote Similarity NPC223427
0.654 Remote Similarity NPC61350
0.6537 Remote Similarity NPC111624
0.6533 Remote Similarity NPC53069
0.6533 Remote Similarity NPC202768
0.6533 Remote Similarity NPC296482
0.6517 Remote Similarity NPC177404
0.6511 Remote Similarity NPC201508
0.6507 Remote Similarity NPC213530
0.6507 Remote Similarity NPC193267
0.6505 Remote Similarity NPC312872
0.6504 Remote Similarity NPC476287
0.649 Remote Similarity NPC472168
0.6484 Remote Similarity NPC11017
0.6478 Remote Similarity NPC132642
0.6471 Remote Similarity NPC245816
0.6471 Remote Similarity NPC476138
0.6465 Remote Similarity NPC141915
0.6465 Remote Similarity NPC280964
0.6465 Remote Similarity NPC114335
0.6463 Remote Similarity NPC473822
0.646 Remote Similarity NPC202605
0.646 Remote Similarity NPC112206
0.6457 Remote Similarity NPC313189
0.6456 Remote Similarity NPC473182
0.6456 Remote Similarity NPC96584
0.6456 Remote Similarity NPC255800
0.6452 Remote Similarity NPC473987
0.645 Remote Similarity NPC310118
0.6446 Remote Similarity NPC208364
0.6444 Remote Similarity NPC167860
0.6444 Remote Similarity NPC123976
0.6438 Remote Similarity NPC473449
0.6435 Remote Similarity NPC289786
0.6429 Remote Similarity NPC475910
0.6425 Remote Similarity NPC291535
0.6425 Remote Similarity NPC475085
0.6425 Remote Similarity NPC475112
0.6409 Remote Similarity NPC315957
0.6409 Remote Similarity NPC19872
0.64 Remote Similarity NPC477548
0.6396 Remote Similarity NPC475774
0.6395 Remote Similarity NPC475271
0.6393 Remote Similarity NPC72211
0.6391 Remote Similarity NPC82070
0.6388 Remote Similarity NPC171409
0.6388 Remote Similarity NPC96405
0.6387 Remote Similarity NPC329631
0.6386 Remote Similarity NPC25899
0.6383 Remote Similarity NPC473185
0.6379 Remote Similarity NPC477795
0.6379 Remote Similarity NPC477532
0.6379 Remote Similarity NPC477806
0.6379 Remote Similarity NPC477805
0.6379 Remote Similarity NPC188400
0.6379 Remote Similarity NPC477796
0.6379 Remote Similarity NPC160100
0.6378 Remote Similarity NPC161292
0.6376 Remote Similarity NPC473053
0.6375 Remote Similarity NPC184680
0.6375 Remote Similarity NPC473183
0.6372 Remote Similarity NPC314834
0.6371 Remote Similarity NPC475253
0.6368 Remote Similarity NPC21638
0.6368 Remote Similarity NPC36229
0.6368 Remote Similarity NPC16452
0.6368 Remote Similarity NPC476581
0.6364 Remote Similarity NPC475844
0.6364 Remote Similarity NPC52254
0.636 Remote Similarity NPC473184
0.6359 Remote Similarity NPC475190
0.6356 Remote Similarity NPC287208
0.6355 Remote Similarity NPC206251
0.6355 Remote Similarity NPC74382
0.6349 Remote Similarity NPC470785
0.6347 Remote Similarity NPC70956
0.6347 Remote Similarity NPC478049
0.6347 Remote Similarity NPC243834
0.6347 Remote Similarity NPC314948
0.6341 Remote Similarity NPC173250
0.6339 Remote Similarity NPC309498

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC308392 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7282 Intermediate Similarity NPD6861 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD5083 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD7284 Clinical (unspecified phase)
0.7116 Intermediate Similarity NPD5863 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD2772 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD2314 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6550 Discontinued
0.7039 Intermediate Similarity NPD8117 Approved
0.7039 Intermediate Similarity NPD8116 Phase 3
0.7035 Intermediate Similarity NPD6553 Clinical (unspecified phase)
0.699 Remote Similarity NPD6393 Clinical (unspecified phase)
0.6951 Remote Similarity NPD7194 Discontinued
0.6944 Remote Similarity NPD3003 Approved
0.6923 Remote Similarity NPD5903 Approved
0.6923 Remote Similarity NPD5902 Approved
0.6916 Remote Similarity NPD7426 Phase 1
0.6916 Remote Similarity NPD7676 Clinical (unspecified phase)
0.6916 Remote Similarity NPD7674 Phase 3
0.6916 Remote Similarity NPD7675 Phase 3
0.6891 Remote Similarity NPD8324 Phase 2
0.6889 Remote Similarity NPD6298 Discontinued
0.6887 Remote Similarity NPD1622 Discontinued
0.6872 Remote Similarity NPD6590 Discontinued
0.6864 Remote Similarity NPD4131 Phase 3
0.6864 Remote Similarity NPD4502 Phase 2
0.6847 Remote Similarity NPD5417 Clinical (unspecified phase)
0.6844 Remote Similarity NPD5930 Phase 3
0.684 Remote Similarity NPD774 Phase 3
0.6829 Remote Similarity NPD4204 Approved
0.6829 Remote Similarity NPD4203 Approved
0.6822 Remote Similarity NPD1768 Approved
0.681 Remote Similarity NPD7558 Phase 2
0.6789 Remote Similarity NPD5530 Phase 1
0.6777 Remote Similarity NPD4372 Phase 1
0.6777 Remote Similarity NPD6569 Phase 2
0.6769 Remote Similarity NPD5640 Discontinued
0.6761 Remote Similarity NPD3477 Phase 2
0.6761 Remote Similarity NPD3478 Clinical (unspecified phase)
0.6756 Remote Similarity NPD6985 Discontinued
0.6738 Remote Similarity NPD6494 Phase 2
0.6712 Remote Similarity NPD2540 Clinical (unspecified phase)
0.671 Remote Similarity NPD8104 Phase 3
0.6699 Remote Similarity NPD5256 Discontinued
0.6683 Remote Similarity NPD4724 Clinical (unspecified phase)
0.6682 Remote Similarity NPD5512 Phase 3
0.6682 Remote Similarity NPD7222 Phase 2
0.6667 Remote Similarity NPD1033 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1034 Phase 3
0.6652 Remote Similarity NPD3875 Discontinued
0.6651 Remote Similarity NPD6769 Clinical (unspecified phase)
0.6651 Remote Similarity NPD6988 Phase 1
0.6636 Remote Similarity NPD6491 Clinical (unspecified phase)
0.6621 Remote Similarity NPD6669 Phase 2
0.6608 Remote Similarity NPD8109 Clinical (unspecified phase)
0.6606 Remote Similarity NPD1392 Approved
0.6604 Remote Similarity NPD4081 Clinical (unspecified phase)
0.6598 Remote Similarity NPD8359 Phase 2
0.6593 Remote Similarity NPD2433 Clinical (unspecified phase)
0.6591 Remote Similarity NPD4035 Approved
0.6591 Remote Similarity NPD32 Approved
0.6591 Remote Similarity NPD4037 Approved
0.6591 Remote Similarity NPD4036 Approved
0.6591 Remote Similarity NPD4122 Approved
0.6591 Remote Similarity NPD4034 Approved
0.6591 Remote Similarity NPD4039 Approved
0.6591 Remote Similarity NPD31 Approved
0.6591 Remote Similarity NPD4033 Approved
0.6591 Remote Similarity NPD4038 Approved
0.6568 Remote Similarity NPD3838 Phase 3
0.6564 Remote Similarity NPD1744 Approved
0.6561 Remote Similarity NPD4305 Clinical (unspecified phase)
0.6548 Remote Similarity NPD789 Phase 2
0.6537 Remote Similarity NPD6306 Phase 2
0.6533 Remote Similarity NPD3816 Phase 1
0.6533 Remote Similarity NPD3815 Phase 1
0.6532 Remote Similarity NPD5429 Discontinued
0.6531 Remote Similarity NPD7859 Phase 2
0.6526 Remote Similarity NPD8063 Discontinued
0.652 Remote Similarity NPD565 Phase 2
0.6518 Remote Similarity NPD8244 Phase 2
0.6516 Remote Similarity NPD5482 Discontinued
0.6512 Remote Similarity NPD6814 Phase 3
0.6504 Remote Similarity NPD8370 Discontinued
0.6494 Remote Similarity NPD1856 Discontinued
0.649 Remote Similarity NPD3920 Phase 2
0.649 Remote Similarity NPD3370 Clinical (unspecified phase)
0.6489 Remote Similarity NPD3570 Phase 2
0.6489 Remote Similarity NPD5416 Discontinued
0.6486 Remote Similarity NPD3842 Clinical (unspecified phase)
0.6481 Remote Similarity NPD1603 Discontinued
0.6481 Remote Similarity NPD1602 Discontinued
0.6473 Remote Similarity NPD6716 Phase 1
0.6468 Remote Similarity NPD8512 Phase 3
0.6463 Remote Similarity NPD5632 Approved
0.6457 Remote Similarity NPD7452 Approved
0.6457 Remote Similarity NPD7453 Approved
0.6457 Remote Similarity NPD6290 Phase 2
0.6453 Remote Similarity NPD6326 Phase 2
0.6449 Remote Similarity NPD6525 Clinical (unspecified phase)
0.6447 Remote Similarity NPD8510 Clinical (unspecified phase)
0.6438 Remote Similarity NPD5547 Clinical (unspecified phase)
0.6438 Remote Similarity NPD6246 Approved
0.6435 Remote Similarity NPD2785 Clinical (unspecified phase)
0.6429 Remote Similarity NPD5658 Approved
0.6429 Remote Similarity NPD3074 Discontinued
0.6425 Remote Similarity NPD5938 Phase 3
0.6423 Remote Similarity NPD6503 Clinical (unspecified phase)
0.6417 Remote Similarity NPD7729 Clinical (unspecified phase)
0.6416 Remote Similarity NPD7703 Clinical (unspecified phase)
0.6409 Remote Similarity NPD1740 Approved
0.6409 Remote Similarity NPD1739 Approved
0.6404 Remote Similarity NPD7538 Clinical (unspecified phase)
0.6404 Remote Similarity NPD863 Approved
0.6404 Remote Similarity NPD861 Approved
0.6404 Remote Similarity NPD862 Approved
0.6402 Remote Similarity NPD4021 Phase 2
0.6394 Remote Similarity NPD4498 Clinical (unspecified phase)
0.6393 Remote Similarity NPD772 Phase 3
0.6391 Remote Similarity NPD7395 Discontinued
0.639 Remote Similarity NPD7025 Clinical (unspecified phase)
0.6388 Remote Similarity NPD7069 Discontinued
0.6388 Remote Similarity NPD4927 Discontinued
0.6387 Remote Similarity NPD4080 Discontinued
0.6387 Remote Similarity NPD6741 Clinical (unspecified phase)
0.6386 Remote Similarity NPD8255 Phase 2
0.6383 Remote Similarity NPD6327 Phase 1
0.638 Remote Similarity NPD6592 Clinical (unspecified phase)
0.6379 Remote Similarity NPD7726 Phase 1
0.6376 Remote Similarity NPD5101 Discontinued
0.6375 Remote Similarity NPD4368 Phase 2
0.6368 Remote Similarity NPD4795 Phase 2
0.6368 Remote Similarity NPD3946 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6159 Phase 2
0.6348 Remote Similarity NPD5059 Clinical (unspecified phase)
0.6345 Remote Similarity NPD8442 Discontinued
0.6344 Remote Similarity NPD5067 Phase 2
0.6344 Remote Similarity NPD7468 Clinical (unspecified phase)
0.6344 Remote Similarity NPD6220 Phase 3
0.6344 Remote Similarity NPD5066 Phase 2
0.6338 Remote Similarity NPD6227 Discontinued
0.6337 Remote Similarity NPD6060 Clinical (unspecified phase)
0.6335 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6329 Remote Similarity NPD5022 Discontinued
0.6322 Remote Similarity NPD2921 Clinical (unspecified phase)
0.6322 Remote Similarity NPD4858 Phase 2
0.6316 Remote Similarity NPD4354 Approved
0.6313 Remote Similarity NPD4324 Phase 2
0.6313 Remote Similarity NPD4325 Phase 2
0.6311 Remote Similarity NPD6573 Phase 3
0.6311 Remote Similarity NPD6572 Phase 2
0.6304 Remote Similarity NPD6643 Discontinued
0.6303 Remote Similarity NPD6962 Phase 2
0.6303 Remote Similarity NPD1505 Phase 2
0.63 Remote Similarity NPD4900 Clinical (unspecified phase)
0.6296 Remote Similarity NPD5316 Approved
0.6295 Remote Similarity NPD5102 Clinical (unspecified phase)
0.6293 Remote Similarity NPD6974 Phase 3
0.6292 Remote Similarity NPD6964 Approved
0.6292 Remote Similarity NPD6963 Approved
0.629 Remote Similarity NPD2175 Phase 3
0.629 Remote Similarity NPD2176 Approved
0.629 Remote Similarity NPD2958 Clinical (unspecified phase)
0.629 Remote Similarity NPD2177 Approved
0.6288 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6282 Remote Similarity NPD6824 Clinical (unspecified phase)
0.6282 Remote Similarity NPD6736 Discontinued
0.6281 Remote Similarity NPD8330 Clinical (unspecified phase)
0.6278 Remote Similarity NPD6477 Clinical (unspecified phase)
0.6275 Remote Similarity NPD5450 Discontinued
0.6275 Remote Similarity NPD7012 Phase 3
0.6275 Remote Similarity NPD7013 Phase 3
0.6273 Remote Similarity NPD4604 Approved
0.6273 Remote Similarity NPD2476 Clinical (unspecified phase)
0.6273 Remote Similarity NPD4605 Approved
0.6272 Remote Similarity NPD3939 Suspended
0.627 Remote Similarity NPD7022 Phase 2
0.627 Remote Similarity NPD7955 Approved
0.627 Remote Similarity NPD7956 Approved
0.6265 Remote Similarity NPD6743 Phase 2
0.6265 Remote Similarity NPD6742 Phase 2
0.6264 Remote Similarity NPD8421 Discontinued
0.6262 Remote Similarity NPD4889 Approved
0.6261 Remote Similarity NPD6140 Clinical (unspecified phase)
0.6261 Remote Similarity NPD7589 Clinical (unspecified phase)
0.6261 Remote Similarity NPD4667 Clinical (unspecified phase)
0.626 Remote Similarity NPD5488 Discontinued
0.6256 Remote Similarity NPD3324 Clinical (unspecified phase)
0.6255 Remote Similarity NPD7548 Discontinued
0.625 Remote Similarity NPD2215 Approved
0.625 Remote Similarity NPD2216 Approved
0.6245 Remote Similarity NPD7413 Phase 3
0.6245 Remote Similarity NPD1941 Approved
0.6245 Remote Similarity NPD7620 Phase 2
0.6245 Remote Similarity NPD7067 Approved
0.6245 Remote Similarity NPD7068 Approved
0.6244 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6239 Remote Similarity NPD3924 Approved
0.6239 Remote Similarity NPD3922 Approved
0.6239 Remote Similarity NPD3923 Approved
0.6239 Remote Similarity NPD4881 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data